Is Palantir Stock a Millionaire Maker?
Palantir (NASDAQ:PLTR) has shot upward over the last year and…
Buy
87
HIMS Quote, Financials, Valuation and Earnings
Last price:
$40.87
Seasonality move
:
12.39%
Day range:
$32.01 - $36.69
52-week range:
$11.20 - $72.98
Dividend yield:
0%
P/E ratio:
66.96x
P/S ratio:
5.80x
P/B ratio:
16.85x
Volume:
42.9M
Avg. volume:
28.1M
1-year change:
189.05%
Market cap:
$8B
Revenue:
$1.5B
EPS (TTM):
$0.54
HIMS Analysts' Consensus Rating
The 12 analysts providing 12-month price projections for Hims & Hers Health shares anticipate an average target of $42.53, ranging from a low estimate of $25.00 to a high estimate of $85.00. This average target implies a growth of 17.62% compared to the current stock price of $36.16.
Consensus Price Target
$42.53
Highest Price Target
$85.00
Lowest Price Target
$25.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 3 | 3 | 3 |
| Hold | 7 | 8 | 8 |
| Sell | 0 | 1 | 1 |
| Consensus | Hold | Hold | Hold |
HIMS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
62
RGC alert for May 2
Regencell Bioscience Holdings [RGC] is down 22.08% over the past day.
Buy
65
MYRG alert for May 2
MYR Group [MYRG] is up 5.11% over the past day.
Sell
35
FTAI alert for May 2
FTAI Aviation [FTAI] is up 3.53% over the past day.
